Podcast

Pharmacy Focus Episode 8: Long-Term Care Outcomes and Cost

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

In this week’s episode, we will be discussing a recent study regarding long-term care outcomes and cost with Russell Procopio, executive vice president of Long-Term Care Pharmacy. Email your pharmacy hero nomination to AAntrim@pharmacytimes.com!

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD
Naloxone concept represented by wooden letter tiles.
Related Content
Celebrating Unique Pharmacist Career Paths That Drive Innovation
October 21st 2024

Celebrating Unique Pharmacist Career Paths That Drive Innovation

Allison Arant
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Marilyn Bulloch Doing Rounds in a Hospital With Physicians
October 14th 2024

Pharmacy Times Launches Behind The Script Campaign to Highlight Pharmacists

Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Schizophrenia disorder and psychiatric disease or mental health as a psychiatry and psychology concept for human abnormal personality behavior and mood illness
October 14th 2024

Improving Schizophrenia Outcomes: The Role of Long-Acting Injectables and Medication Adherence

Brooke Kempf, PMHNP
FDA Approves Marstacimab-hncq for Adults, Adolescents With Hemophilia A or B Without Inhibitors
October 11th 2024

FDA Approves Marstacimab-hncq for Adults, Adolescents With Hemophilia A or B Without Inhibitors

Aislinn Antrim, Assistant Managing Editor